Safety of High-intensity Treatment with the Irreversible Monoamine Oxidase Inhibitor Tranylcypromine in Patients with Treatment-resistant Depression
2019 ◽
Vol 250
◽
pp. 199-203
◽
2018 ◽
Vol 83
(9)
◽
pp. S304
◽
2020 ◽
Vol 40
(5)
◽
pp. 515-517
2019 ◽
Vol 39
(6)
◽
pp. 649-652